ID   RCC-53
AC   CVCL_C3HR
SY   RCC53
DR   GEO; GSE40301
DR   Wikidata; Q114312777
RX   PubMed=16045799;
RX   PubMed=16261161;
RX   PubMed=23667903;
CC   HLA typing: A*02:01,25:01; B*15:01,18:01; C*03:03,12:03 (PubMed=16045799).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=16045799; DOI=10.1186/1479-5876-3-29; PMCID=PMC1188079;
RA   Geiger C., Regn S., Weinzierl A., Noessner E., Schendel D.J.;
RT   "A generic RNA-pulsed dendritic cell vaccine strategy for renal cell
RT   carcinoma.";
RL   J. Transl. Med. 3:29.1-29.15(2005).
//
RX   PubMed=16261161; DOI=10.1038/sj.onc.1209188;
RA   Djafarzadeh R., Noessner E., Engelmann H., Schendel D.J.,
RA   Notohamiprodjo M., von Luettichau I., Nelson P.J.;
RT   "GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive
RT   to FAS-meditated killing.";
RL   Oncogene 25:1496-1508(2006).
//
RX   PubMed=23667903; DOI=10.1515/hsz-2012-0188;
RA   Notohamiprodjo S., Djafarzadeh R., Rieth N., Hofstetter M.,
RA   Jaeckel C., Nelson P.J.;
RT   "Cell surface engineering of renal cell carcinoma with
RT   glycosylphosphatidylinositol-anchored TIMP-1 blocks TGF-beta 1
RT   activation and reduces regulatory ID gene expression.";
RL   Biol. Chem. 393:1463-1470(2012).
//